x
0
 
Popular Searches
SCOTTRADE ACCOUNT IT'S TIME. It's time for an easier way to invest. Open a Scottrade Account
Apply Now

AstraZeneca PLC (AZN)

 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio  
Add to/Remove from a Portfolio
4,612.50 +89.00    +1.97%
22/07 - Closed. Currency in GBP ( Disclaimer )
Type: Equity
Market: United Kingdom
ISIN: GB0009895292 
SEDOL: 0989529

  • Prev. Close: 4,612.50
  • Open: 4,546.50
  • Day's Range: 4,529.00 - 4,616.50
START TRADING NOW
AstraZeneca 4,612.50 +89.00 +1.97%
Add to/Remove from a Portfolio  
Add to/Remove from a Portfolio

AZN Overview

Prev. Close4,612.5
Day's Range4,529 - 4,616.5
Revenue17.16B
Open4,546.5
52 wk Range3,680 - 4,634
EPS1.76
Volume2,403,598
Market Cap58.89B
Dividend (Yield)2.14 (4.09%)
Average Vol. (3m)2,674,404
P/E Ratio26.43
Beta0.65
1-Year Return7.43%
Shares Outstanding1,264,615,978
Next Earnings DateJul 28, 2016

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

AstraZeneca PLC News & Analysis

News


AstraZeneca PLC Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Real-time CFD 4,612.50 - - - +1.97% GBP 22/07  
  BATS Europe 4,608.0 0.0 0.0 486,448 +1.69% GBP 22/07  
  London 4,612.5 4,550.0 4,620.0 2,403,598 +1.97% GBP 22/07  
  OTC Markets 61.200 0.000 0.000 775 +2.86% USD 22/07  
  Real-time CFD 31.13 - - - +1.97% USD 22/07  
  Mexico 570.200 0.000 0.000 0 0.00% MXN 21/07  
  Stockholm 528.5 0.0 0.0 576,422 +1.05% SEK 22/07  
  BATS Europe 529.0 0.0 0.0 133,791 +1.15% SEK 22/07  
  Frankfurt 55.74 0.00 0.00 180 +1.11% EUR 22/07  
  Munich 54.900 0.000 0.000 0 -0.88% EUR 22/07  
  Xetra 55.630 55.000 56.350 1,264 +0.83% EUR 22/07  
  Stuttgart 56.534 0.000 0.000 25 +2.53% EUR 22/07  
  TradeGate 56.145 56.248 56.937 602 +0.78% EUR 22/07  

Trending Stocks

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 98.66 99.30 98.31 -0.77 -0.77% 28.31M 22/07  
  SBI 223.50 225.90 222.10 -2.15 -0.95% 12.34M 22/07  
  Amazon.com 744.86 751.28 743.53 +0.43 +0.06% 2.28M 22/07  
  Microsoft 56.57 56.63 55.78 +0.77 +1.38% 32.16M 22/07  
  Nintendo Ltd 28,220.0 29,920.0 27,170.0 +220.0 +0.79% 25.41M 22/07  
  Cipla 520.40 522.90 512.35 +4.55 +0.88% 1.19M 22/07  
  Biocon 809.70 825.00 710.95 +109.10 +15.57% 14.41M 22/07  
  Nintendo Co 29.00 30.00 27.75 -3.42 -10.55% 8.18M 22/07  
  Tesla 222.27 224.50 218.88 +1.77 +0.80% 2.58M 22/07  
  UPL 584.10 586.00 560.30 +25.00 +4.47% 2.23M 22/07  

AstraZeneca PLC Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

61500

Equity Type

ORD

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas. The Company has its operations in over 100 countries. The Company's pipeline includes over 150 projects of which approximately 125 are in the clinical phase of development. The Company is developing a Toll-like receptor 9 (TLR-9) receptor agonist aimed at producing long-term benefit in asthma by addressing imbalances in the immune system. AstraZeneca offers various products, including Accolate, Rhinocort, Bricanyl Turbuhaler, Rhinocort, Symbicort pMDI, Crestor, Seloken/Toprol-XL, Brilinta/Brilique (ticagrelor), Bydureon, Xigduo XR, Kombiglyze XR and metformin XR, among others.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit  
National Securities Depository (India), National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $2000 Start Trading
Securities and Exchange Commission (United States) $2500 Start Trading
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong) $250 Start Trading
Securities and Exchange Commission (United States) $100 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
0%
Bearish
100%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Add Chart to Comment
Astrazeneca
 
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.